See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516479_2017_Insys_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 251.26618705035972, 'aggregate_val': 210390000, 'exp_sum': 834000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 834000}} |
Graph
Absolute values for 0001516479, Insys Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 230,972,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 43,172,000 |
| 3 | remainder_Assets | 81,992,000 |
| 4 | LiabilitiesCurrent | 78,614,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 7,933,000 |
| 7 | CostOfGoodsAndServicesSold | -661,071 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,726,175 |
| 9 | ResearchAndDevelopmentExpense | 15,992,294 |
| 10 | remainder_Expenses | 638,266,657 |
| 11 | remainder_Revenues | 175,631,366 |
| 12 | remainder_NetIncome | 145,856 |
| 13 | remainder_ComprehensiveNetIncome | -165,718 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 356,136,000 |
| 1 | Liabilities | 86,547,000 |
| 2 | Expenses | 663,324,055 |
| 3 | Revenues | 175,631,366 |
| 4 | StockholdersEquity | 269,589,000 |
| 5 | NetIncome | -487,546,833 |
| 6 | ComprehensiveNetIncome | -487,629,692 |
| 7 | BaseVar | 640,974,998 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.452 |
| 9 | EconomicCapitalRatio | 1.84 |
Edgar->Model Mapping
Feature Distribution
Change over Time
